Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

MHRA issues recall of urinary incontinence drug

  • Comment

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class one recall of Oxybutynin Hydrochloride, a drug used to treat urinary incontinence.

Four batches of 5mg tablets of the drug have been recalled by the agency over fears they may contain too much active ingredient. The affected batch numbers are 09D02, 09D04, 146401 and 146402.

According to the MHRA, high levels of the active ingredient have been found during early stages of production of the drug. Although the finished tablets may not be affected, the agency are recalling the batches as a precautionary measure while an investigation takes place.

Oxybutynin Hydrochloride is used to treat bladder conditions, such as urinary incontinence, and is often taken by children with an uncontrollable nocturnal bladder or the elderly.

 

The affected batches are:

LiveryBatch NoExpiry DatePack SizeFirst Distributed
Niche09D0212/20118416/04/2009
Niche09D0412/20118416/04/2009
Actavis14640112/20115605/05/2009
Actavis14640212/20115622/05/2009
  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs